Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients with Moderate to Severe Systemic Lupus Erythematosus

Oct 16, 2024

Posted by Cullinan Therapeutics

EVERSANA Named a Great Place to Work for Six Consecutive Years; Now Certified Across Nine Countries

Oct 16, 2024

Posted by EVERSANA

Join Our Upcoming Webinar on LNP Characterization on Thursday, October 31st!

Oct 16, 2024

Posted by Phosphorex

VIDEO: Driving Biopharma Forward—The Role of Technology in Commercialization

Oct 16, 2024

Posted by Corval

EVERSANA Transforms Pharmacovigilance & Drug Safety Industry with Oracle Collaboration, New Global Patient Support Model

Oct 10, 2024

Posted by EVERSANA

Lundbeck Global Golden Ticket Competition

Oct 08, 2024

Biopharma Technology LLC is thrilled to announce a strategic partnership with Arete Biosciences!

Oct 08, 2024

Posted by Biopharma Process Systems

AscellaHealth Showcases End-to-End Specialty Pharmaceutical Commercialisation Solutions at World Orphan Drug Congress, Shapes Future of Rare and Orphan Disease Therapies

Oct 04, 2024

Real Chemistry and Corval Partner to Elevate Biopharma Commercialization

Oct 03, 2024

Posted by Corval

Read our latest article in Pharma Perspectives on Market Access

Sep 26, 2024